Intercept Pharmaceuticals (ICPT) Debt/EBITDA US GAAP (year values) |
||||||||
2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | |||
Debt/EBITDA | 0.23 | 0.39 | -0.46 | -2.20 | 2.56 | 2.37 | ||
Changes by years, y/y, % | -127% | +68% | -218% | +374% | -217% |
Intercept Pharmaceuticals. Debt/EBITDA
Intercept Pharmaceuticals. Debt/EBITDA, changes, %
Intercept Pharmaceuticals (ICPT) Debt/EBITDA US GAAP (quarter values) |
||||||||
2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | LTM ? | |||
Debt/EBITDA | 1.00 | 3.36 | 1.55 | 1.50 | 2.37 | 2.37 | ||
Changes by years, y/y, % | -145% | +461% | -158% | -168% | +137% | |||
Changes by quarters, q/q, % | -145% | +237% | -54% | -3% | +58% |